Hepatitis C Community
new research
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

new research

I am so happy to hear of any research for HCV that doesn't include interferon.
Thanks to mikesimon for letting me about this one.

(May 5, 2009 09:00 PM
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model of the disease.)

(August 6, 2009)

The University of Massachusetts Medical School's MassBiologics laboratory in Boston has begun the first phase of a clinical trial of a new Hepatitis C treatment.
The treatment is based on an antibody called MBL-HCV1. It will be given to 30 volunteers in escalating doses until the trial concludes later this year. A second phase will focus on liver transplant patients.

Hepatitis C attacks the liver and can lead to liver failure. The virus kills about 10,000 people annually and more than 3 million Americans are chronically infected with Hepatitis C.

The antibody developed by MassBiologics is designed to be used shortly before and after liver transplant surgery. Researchers also think it could be used in patients that are newly diagnosed with Hepatitis C.
MassBiologics is a nonprofit, licensed manufacturer of vaccines and other biologic products. The laboratory produces 30 percent of the United States' tetanus/diphtheria vaccine supply. It is run by UMass Medical School professor Donna Ambrosino.
Related Discussions
2 Comments Post a Comment
Blank
751342_tn?1297434382
Boy wouldn't that be nice if that one pans out. Most of my problems with sx were due to interferon.
Blank
Avatar_f_tn
This sounds very encouraging. Thank you for posting this.
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
748543_tn?1371753642
Blank
TMJ/TMJ The Connection Between Teet...
Jan 27 by Hamidreza Nassery , DMD, FICOI, FAGDBlank
469720_tn?1388149949
Blank
Abdominal Aortic Aneurysm-treatable... Blank
Oct 04 by Lee Kirksey, MDBlank
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
446474_tn?1404424777
Blank
HectorSF
CA
317787_tn?1424342395
Blank
Dee1956
DC
683231_tn?1415953923
Blank
flyinlynn
Auburn, WA
Avatar_m_tn
Blank
can-do-man
IN
Avatar_f_tn
Blank
patra_
DeLand, FL
Avatar_f_tn
Blank
Livelife777
FL